Announcements Trials
Browse Landscape

Phase

Phase 1/2 2

Status

Terminated 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other solid neoplasm 2

Conditions

Advanced Solid Tumors 2

Interventions

Injections 7pembrolizumab 5Paclitaxel 5Bevacizumab 5Leucovorin 4Fluorouracil 4Carboplatin 4trifluridine tipiracil drug combination 3Pemetrexed 3Oxaliplatin 3Irinotecan 3Docetaxel 3Capecitabine 3toripalimab 2tislelizumab 2fludarabine 2Nivolumab 2Gemcitabine 2Fulvestrant 2Cisplatin 2BMS-753493 2130-nm albumin-bound paclitaxel 2urelumab 1ulixertinib 1palbociclib 1mogamulizumab 1lenvatinib 1fluzoparib 1duvelisib 1durvalumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1/2 × Advanced Solid Tumors × BMS-753493 × Clear all
NCT00546247 2015-10-12

A Phase 1/2 Study of Epofolate (BMS-753493) in Subjects With Advanced Cancer (Schedule 1)

Bristol-Myers Squibb

Phase 1/2 Terminated
26 enrolled
Other solid neoplasm

Advanced Solid Tumors

NCT00550017 2015-10-12

A Phase 1/2 Study of Epofolate (BMS-753493) in Subjects With Advanced Cancer (Schedule 2)

Bristol-Myers Squibb

Phase 1/2 Terminated
39 enrolled
Other solid neoplasm

Advanced Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡